Effervescent tablets which contain an effervescent mixture of a suitable organic acid and an alkali metal bicarbonate and/or carbonate can give out carbon dioxide when they meet water. The effervescent tablets for oral solution can be dissolved in cool water about 17-20 degrees C, therefore it is convenient to carry and use. It also has a good taste for patient with deodorizing agent added. The foam produced by external effervescent tablets is usually helpful in killing the local bacteria. The review displayed the main supplementary material, preparative technique and the study development of effervescent tablets of Chinese traditional medicine. Effervescent tablets that have been used to clinic were enumerated.
Citric Acid ; Drugs, Chinese Herbal ; administration & dosage ; Plants, Medicinal ; Polyethylene Glycols ; Sodium Bicarbonate ; Tablets ; Technology, Pharmaceutical

OBJECTIVE: To investigate the efficacy and safety of intravesical instillation of heparin/alkalized lidocaine (lidocaine mixed with sodium bicarbonate) combined with hydrodistension and transurethral fulguration in the treatment of female interstitial cystitis (IC). METHODS: Female patients who attended the Department of Urology at the First Hospital of China Medical University between January 2012 and December 2020 and met the diagnostic criteria proposed in the guidelines of the American Urological Association with a new diagnosis of IC were selected for retrospective analysis. Cystoscopy and biopsy of suspicious lesions were performed at the time of diagnosis. All the patients were treated with an intravesical instillation regimen of 2% lidocaine 10 mL + 5% sodium bicarbonate 5 mL + heparin 25 000 IU for a continuous period of 12 months, with or without water dilatation and transurethral electrocautery according to the patient's preference, categorized as hydrodistension and transurethral fulguration (HD/TF) group and non-HD/TF group. The patients were evaluated before and 1, 6, and 12 months after treatment for O'Leary-Sant interstitial cystitis patient symptom index scores (ICSI), interstitial cystitis patient problem index scores (ICPI), visual analog scale (VAS) of suprapubic pain, and functional bladder capacity (FBC) changes. RESULTS: A total of 79 patients were collected in this study. Four (5.1%) of these patients underwent cystectomy due to pathological diagnosis of cancer or treatment failure. The remaining patients were followed up 1, 6 and 12 months after treatment. Repeated-measures ANOVA showed a significant decrease in ICPI, ICSI and VAS and an increase in FBC after treatment compared with before treatment (P < 0.05). FBC continued to decrease during the 1, 6 and 12 months' post-treatment follow-ups, with statistically significant differences; ICSI continued to decrease during the 1 and 6 months post-treatment follow-ups, with statistically significant differences, while the difference between ICSI at 6 months post-treatment and at 12 months' post-treatment was not statistically significant. In the HD/TF group, ICPI continued to decrease in the follow-up from 1 and 6 months after treatment, and the difference was statistically significant, while the difference between ICPI 6 months after treatment and 12 months after treatment was not statistically significant. There was no statistically significant difference between the remaining indicators 1, 6 and 12 months after treatment. ICPI, ICSI, VAS and FBC improved earlier and the changes in VAS and FBC were more significant in the HD/TF group compared with the non-HD/TF group (P < 0.05). CONCLUSION Heparin/alkalized lidocaine combination of intravesical instillation with hydrodistension and transurethral fulguration for IC is an effective treatment option. Heparin/alkalized lidocaine combination of intravesical instillation may be the first choice of treatment, which can significantly reduce the economic burden of patients and medical insurance system. If patients can accept it, transurethral fulguration with hydrodistension may be considered.
Humans ; Female ; Cystitis, Interstitial/drug therapy* ; Administration, Intravesical ; Retrospective Studies ; Sodium Bicarbonate/therapeutic use* ; Treatment Outcome ; Lidocaine/therapeutic use* ; Heparin/therapeutic use* ; Electrocoagulation

The present study is an attempt to delineate the effect of various salt administrations on the changes of blood pH and electrolytes, especially the nature of serum calcium, total and ionic, and serum magnesium. Thirty five male rabbits weighing 1.9 to 2. 5kg were used in this experiment. At the end of the three days diet adjustment period, the animals were divided into seven groups; Group I; Control, Group II; Ammonium chloride oral administration, Group III; Oral administration of sodium bicarbonate, Group IV; Potassium chloride intraveneous injection, Group V; Sodium chloride intravenous injection, Group VI; Calcium chloride intravenous injection, and Group VII; Magnesium chloride intravenous injection. The blood pH was determined by the method by Astrup and bicarbonate in serum by the method of Van Slyke and Neill. Sodium and potassium in serum were determined with an EEL flame photometer. Chloride was determined by the method of Schales and Schales and inorganic phosphorous by the method of Fiske and Subbarrow. Serum total calcium and magnesium were determined according to the method of chelometric titration with Eriochrome blue S.E. Serum ionic calcium was determined by the method of Yanagisawa. The results of this study are as follows: 1. The oral administration of ammonium chloride produced a significant decrease in blood pH. The serum concentrations of bicarbonate, magnesium and potassium were steadily decreased, but serum chloride, serum total and ionic calcium concentrations were increased through the experiment. 2. Sodium bicarbonate ingestion increased the concentration of bicarbonate, magnesium and serum ionic calcium markedly and serum ionic calcium slightly. The blood pH was significantly increased but serum chloride concentration was markedly reduced after ingestion of sodium bicarbonate However, serum potassium and inorganic phosphorus concentrations were decreased slightly. 3. The blood pH was dropped in the first two hours of intravenous injection of potassium chloride and tended to rise again significantly. the concentration of sodium and chloride in serum was increased markedly in two hours of injection but reduced after six hours to control level. Serum phosphorus, total and ionic calcium were reduced steadily, but serum concentration of magnesium, potassium and bicarbonate concentrations were slightly increased through the experiment 4. After sodium chloride was given, intravenously, there was a sustained increase in the concentration of serum sodium, potassium, phosphorus and bicarbonate but the blood pH was decreased in the first two hours and significantly elevated through the experiment. The serum concentration of chloride, magnesium, total and ionic calcium was decreased slightly. 5. B100d pH was slightly increased and the concentration of chloride was elevated sharply after injection of calcium chloride intravenously in the first two hours and come to control level in twenty-four hours. Serum sodium concentration was elevated steadily through the experiment. The concentration of total and ionic calcium in serum was elevated after injection but come to control level in twenty four hours of injection. Serum potassium and magnesium concentrations were decreased slightly in the first two hours and increased in four hours of injection. 6. Magnesium chloride intravenous injection produced a decrease in blood pH and serum concentration of bicarbonate in the first few hours and increase after 6 hours of injection. Serum magnesium, and inorganic phosphorus levels were increased after injection but the concentration of inorganic phosphrous was decreased markedly in twenty four hours of injection. Serum concentration of chloride, ionic calcium and potassium wag markedly reduced.
Administration, Oral ; Ammonium Chloride ; Animals ; Calcium ; Calcium Chloride ; Diet ; Eating ; Eels ; Electrolytes* ; Humans ; Hydrogen-Ion Concentration* ; Injections, Intravenous ; Magnesium ; Magnesium Chloride ; Male ; Phosphorus ; Potassium ; Potassium Chloride ; Rabbits ; Sodium ; Sodium Bicarbonate ; Sodium Chloride

Metabolic acidosis is a cause of renal disease progression, and alkali therapy ameliorates its progression. However, there are few reports on the role of renal acid-base transporters during alkali therapy. We evaluated the effect of sodium bicarbonate therapy and the role of acid-base transporters on renal disease progression in rats with a remnant kidney. Sprague-Dawley rats consumed dietary sodium bicarbonate (NaHCO3) or sodium chloride (NaCl) with 20% casein after a 5/6 nephrectomy. After being provided with a casein diet, the NaHCO3-treated group had higher levels of serum bicarbonate than the control group. At week 4, the glomerular filtration rate in the NaHCO3 group was higher than that in the NaCl group, and the difference became prominent at week 10. The glomerulosclerosis and tubulointerstitial damage indices in the NaHCO3 group were less severe compared with controls at week 4 and 10. The expression of the Na/H exchanger (NHE) was decreased, and apical reactivity was decreased in the NaHCO3 group, compared with the NaCl group. Endothelin-1 levels in the kidney were also decreased in the NaHCO3 group. Dietary sodium bicarbonate has the effects of ameliorating renal disease progression, which may be related to the altered expression of NHE in the remaining kidney.
Acidosis/*drug therapy ; Alkalies/*therapeutic use ; Animals ; Caseins/administration & dosage ; Disease Progression ; Glomerular Filtration Rate/drug effects ; Glomerulosclerosis, Focal Segmental/drug therapy ; Kidney/injuries ; Male ; Nephrectomy ; Nephritis, Interstitial/drug therapy ; Rats ; Rats, Sprague-Dawley ; Renal Insufficiency/*drug therapy ; Sodium Bicarbonate/*therapeutic use ; Sodium Chloride/administration & dosage ; Sodium-Hydrogen Antiporter/*antagonists & inhibitors

PURPOSE: This study was performed to find out the effects of lidocaine or 8.4% sodium bicarbonate mixed with rocuronium on mean arterial pressure, heart rate and withdrawal movement. METHODS: Data collection was performed from December 15, 2006 through May 31, 2007. Seventy-five patients with American Society Anesthesiologist (ASA) physical status I & II, under general anesthesia, were randomly assigned to 1 of 3 groups: R group (RG) received rocuronium 0.6 mg/kg; RL group (RLG), rocuronium 0.6 mg/kg mixed with 2 mL of 2% lidocaine; RS group (RSG), rocuronium 0.6 mg/kg with the same volume of 8.4% sodium bicarbonate. Mean arterial pressure, heart rate and withdrawal movement were observed from its injection until 5 min after endotracheal intubation. RESULTS: The incidence of withdrawal movement with its corresponding injections was 72%, 40% and 4% in RG, RLG and RSG, respectively (p<.001). Score of withdrawal movement was the lowest in RSG of all groups (p<.001). While mean arterial pressure (p=.011) in RSG decreased significantly, and heart rate (p=.003) in RG increased more with its injection than before induction of anesthesia. CONCLUSION: Administration of the equivalent volume of 8.4% sodium bicarbonate with rocuronium is more effective than that of lidocaine with rocuronium compared with rocuronium only, in preventing withdrawal movement and in stabilizing mean arterial pressure and heart rate.
Adult ; Androstanols/administration & dosage/*adverse effects ; Anesthetics, Local/administration & dosage/*therapeutic use ; Blood Pressure/*drug effects ; Female ; Heart Rate/*drug effects ; Humans ; Injections, Intravenous ; Lidocaine/administration & dosage/*therapeutic use ; Male ; Middle Aged ; Neuromuscular Nondepolarizing Agents/administration & dosage/*adverse effects ; Pain/*prevention & control ; Sodium Bicarbonate/*administration & dosage